4.87
-0.1(-2.01%)
Currency In USD
| Previous Close | 4.97 |
| Open | 4.93 |
| Day High | 5.07 |
| Day Low | 4.83 |
| 52-Week High | 7.3 |
| 52-Week Low | 2.37 |
| Volume | 1.09M |
| Average Volume | 1.19M |
| Market Cap | 622.69M |
| PE | -44.27 |
| EPS | -0.11 |
| Moving Average 50 Days | 4.59 |
| Moving Average 200 Days | 3.89 |
| Change | -0.1 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $259.59 as of December 14, 2025 at a share price of $4.87. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $424.96 as of December 14, 2025 at a share price of $4.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
GlobeNewswire Inc.
Nov 12, 2025 10:00 PM GMT
America's Growth Leaders Cytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026. Presented in partnership with global data firm Statista, the ranking recognizes the top-performing publicly listed companies in the
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
GlobeNewswire Inc.
Nov 06, 2025 10:00 PM GMT
BioTech Breakthrough Awards The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CT
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
GlobeNewswire Inc.
Oct 29, 2025 9:00 PM GMT
Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants Cytek research initiative Cytek is supporting ISAC in a shared mission to extend flow cytometry reach worldwide. In th